Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
Recruiting · NCT05754593 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Bordeaux
View the official record on ClinicalTrials.gov →Interventions studied
Anti-Mullerian hormone (AMH) levelAntral follicle count (AFC)Clinical assessment
What this trial is about
The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.
Who can take part
Age range
25 Years to 35 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Reproductive women between 25 and 35 years old ;
- MS Patient : Diagnosis of multiple sclerosis based on McDonald Criteria 2017;
- French-speaking, without comprehension disorders ;
- being affiliated to health insurance ;
- Willing to participate and to sign informed consent.
Exclusion criteria
- History of ovarian surgery (cystectomy, annexectomy) ;
- Turner Syndrome ;
- fragile X messenger ribonucleoprotein 1 (FMR1) premutation ;
- Endometriosis with a risk of ovarian reserve alteration ;
- History of chemotherapy or pelvic radiotherapy ;
- Pregnant or breastfeeding women ;
- patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).
Where it is running
1 location listed.
- CHU de Bordeaux - service de neurologie - Bordeaux, France